sentence_eng_Latn: “The EU approval of Perjeta is the result of years of research into the HER2 pathway and we are excited to offer a new treatment option for people with this aggressive disease,” said Hal Barron, M.D., Chief Medical Officer and Head, Global Product Development. “The combination of Perjeta, Herceptin
sentence_dyu_Latn: “UE ka bèn Perjeta kan yé san dama gnagnini jaabi léyé kata HER2 tamasirala wa an kônônasurukula ka furakèli kura di ni bana jugu bé mah muna “Ka bô Hal Baron da, M.D., dôgôtôrôba ani duniya nafamafènw yiriwali gnamôgô.”Perjeta ni Herceptin farini gnôngôn kan